Being a 'morning person' linked to lower risk of breast cancer

June 26, 2019

Being a morning person (popularly known as larks) is associated with a lower risk of developing breast cancer than being an evening person (popularly known as owls), finds a study published by The BMJ today.

Sleeping longer than the recommended 7-8 hours a night may also carry an increased risk, the results suggest.

The authors have previously posted a non-peer reviewed, unedited version of this research paper on a recognised preprint server* and presented it at the NCRI Cancer Conference in November 2018.

One in seven women will develop breast cancer at some stage in their lives. Previous studies have shown a link between night shift work and risk of breast cancer, thought to be due to disrupted sleep patterns, light exposure at night, and other lifestyle factors. But there has been much less research into the potential effects of sleep habits on breast cancer risk.

So an international research team set out to examine whether certain sleep traits could have a direct (causal) effect on risk of developing breast cancer.

Using a technique called Mendelian randomisation, they analysed genetic variants associated with three particular sleep traits - morning or evening preference (chronotype), sleep duration, and insomnia - for 180,216 women in the UK Biobank study and 228,951 women in the Breast Cancer Association Consortium (BCAC) study.

Analysing genetic information in this way avoids some of the problems that afflict traditional observational studies, making the results less prone to unmeasured (confounding) factors, and therefore more likely to be reliable.

An association that is observed using Mendelian randomisation strengthens the inference of a causal relationship.

In observational analysis of UK Biobank data, morning preference was associated with a slightly lower risk of breast cancer (one less woman per 100) than evening preference, whereas there was little evidence for an association with sleep duration and insomnia symptoms.

However, the authors stress that this represents differences at the extreme ends of the scale, and that the extent of effect is likely to be smaller than that of other known risk factors for breast cancer, such as BMI and alcohol intake.

Mendelian analysis of UK Biobank data provided some supportive evidence for a protective effect of morning preference on breast cancer risk, but imprecise estimates for sleep duration and insomnia symptoms.

Mendelian analysis from BCAC also supported a protective effect of morning preference, and showed a potential harmful effect of longer sleep duration (more than the recommended 7-8 hours) on breast cancer, whereas evidence for insomnia symptoms was inconsistent.

The researchers point to some limitations, for example the study partly relied on self-reported sleep measures and was restricted to women of European ancestry, so findings may not be applicable to other groups.

However, they used several methods to assess data from two high quality resources, and took account of established and potential risk factors. Results also remained largely unchanged after further sensitivity analyses.

As such, the researchers say their findings "provide strong evidence for a causal effect of chronotype on breast cancer risk." Further work to uncover possible reasons for the associations between sleep disruption and breast cancer is required, they add. Nonetheless, these findings "have potential implications for influencing sleep habits of the general population in order to improve health."

In a linked editorial, Professor Eva Schernhammer from the University of Vienna says these findings "identify a need for future research exploring how the stresses on our biological clock can be reduced."

This offers a tremendous opportunity for preserving good health, achieving healthy aging, and, more specifically, for developing new personalised strategies for reducing the risk of chronic diseases associated with the circadian system, she adds.

This line of research "could also help to align working hours with chronotype--to more closely match externally imposed timing with individual diurnal preference, especially in the working population," she concludes.
-end-
Peer-reviewed? Yes (research); No (linked editorial)
Type of evidence: Observational; Mendelian randomisation; Opinion
Subjects: Women

BMJ

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.